Abnormal cannabidiol GPR18. Another possible target of abnormal cannabidiol is GPR55, which has also received much attention as a putative cannabinoid receptor, although a growing body of evidence points to lysophosphatidylinositol (LPI) as the endogenous ligand for GPR55. Further research suggests there are yet more additional cannabinoid receptors. Research of the effects on abnormal cannabidiol in mice has indicated that atypical cannabinoids have therapeutic potential in a variety of inflammatory conditions, including those of the gastrointestinal tract. After inducing colitis by means of trinitrobenzene sulfonic acid, wound healing of both human umbilical vein endothelial and epithelial cells was enhanced by the Abn-CBD.
Abnormal return where: AR - abnormal return for firm i on day t R - actual return for firm i on day t E(R) – expected return for firm i on day t A common practice is to standardise the abnormal returns with the use of the following formula: formula_3 where: SAR - standardised abnormal returns SD – standard deviation of the abnormal returns The SD is calculated with the use of the following formula: formula_4 where: S – the residual variance for firm i, R – the return on the stock market index on day t, R – the average return